{"disease":{"id":"severe-uncontrolled-asthma","name":"severe uncontrolled asthma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06681545","title":"Exploring the Lived Experience of Young Adults With Severe Asthma","phase":"","overall_status":"RECRUITING","enrollment_count":46,"lead_sponsor_name":"Manchester University NHS Foundation Trust","has_results":false},{"nct_id":"NCT04305405","title":"PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT04200326","title":"Real-life First Dose Effect of Fasenra in Patients With Severe Uncontrolled Asthma","phase":"","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"AstraZeneca","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}